Carl v. Johnson & Johnson
(N.J., filed October 5, 2020): Urging the New Jersey Supreme Court to review a lower court’s incorrect application of the state’s expert evidence standard. Arguing that the Court needs to overturn the decision to reinforce the message of its opinion in In re Accutane. The opinion, if not reversed, will leave trial courts with great uncertainty as to the gatekeeping role in New Jersey’s many drug, tort and product lawsuits.
Latest News
View all news
More Work Remains on Tort Reform
This letter-to-the-editor was originally published by The Herald-Dispatch in Huntington, WV. West Virginia was a mainstay on the American Tort Reform Foundation’s “Judicial Hellholes®” list for nearly 20 years, finally […]
Fla.’s Legal Reform Package Makes It a Judicial Hellholes Point of Light
This op-ed was originally published by DC Journal – Inside Sources. With Florida’s 2023 legislative session in the rearview mirror, Gov. Ron DeSantis remains under a microscope with pundits and […]
Lawmakers Denounced for Pushing Punitive Damages in Last-Minute Amendment
Illinois Businesses Brace for Increased Costs and Diminished Appeal as Trial Bar Pushes for Punitive Damages in Wrongful Death Cases
ATRA President Tiger Joyce on WFLA-FM Tallahassee
ATRA President Tiger Joyce discusses Florida’s 2023 legal reform successes with Preston Scott on WFLA-FM Tallahassee.
Florida Named Judicial Hellholes Point of Light, DeSantis’s Efforts Praised
2023 legislative session resulted in landmark legal reforms, ATRF says
New Florida Bill to Regulate Misleading Legal Services Ads on Pharmaceutical Drugs and Medical Devices
ATRA’s Latest Data Reveals $271.8 Million Spent on Legal Services Advertising in Florida in 2022; Florida Accounted for Nearly 20% of Radio Ad Spending Nationwide